Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.Conditions: Malignant Pleural Mesothelioma
Sponsors: Erasmus Medical Center
Phase I
June 1, 2010 | 3 References Cancer - Mesothelioma mRNA-transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Conditions: Uveal Melanoma
Sponsors: Radboud University Nijmegen Medical Centre
Phase n/a
April 14, 2009 Cancer - Melanoma Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy
Conditions: Melanoma
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockefeller University
Phase I
June 17, 2008 | 1 Reference Cancer - Melanoma DTH, Dendritic Cell, Diagnostic Antigen Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Sponsors: Duke University, National Institute of Neurological Disorders and Stroke
Phase II
March 25, 2008 | 3 References Cancer - Brain & CNS Condition: Renal Transplant
Sponsors: Hoffman-La Roche Inc.
Phase: IV
April 6, 2007 Transplant Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Melanoma (Skin)
Sponsors: University of Pittsburgh
Phase I
October 18, 2006 Cancer - Melanoma Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients
Conditions: Colorectal Cancer, Liver Metastases
Sponsors: Radboud University
Phase I, II
September 27, 2005 | 5 References Cancer - Colon, Cancer - Liver